Tam, Lai Shan;
Wei, James Cheng-Chung;
Aggarwal, Amita;
Baek, Han Joo;
Cheung, Peter P;
Chiowchanwisawakit, Praveena;
Dans, Leonila;
Gu, Jieruo;
Hagino, Noboru;
Kishimoto, Mitsumasa;
Reyes, Heizel Manapat;
Soroosh, Soosan;
Stebbings, Simon;
Whittle, Samuel;
Yeap, Swan Sim;
Lau, Chak Sing.
Despite the availability of axial spondyloarthritis (SpA) recommendations proposed by various rheumatology societies, we considered that a region-specific guideline was of substantial added value to clinicians of the Asia-Pacific region, given the wide variations in predisposition to infections and other...
This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthca...
Ward, M. M;
Deodhar, A;
Akl, E. A;
Lui, A;
Ermann, J;
Gensler, L. S;
Smith, J. A;
Borenstein, D;
Hiratzka, J;
Weiss, P. F;
Inman, R. D;
Majithia, V;
Haroon, N;
Maksymowych, W. P;
Joyce, J;
Clark, B. M;
Colbert, R. A;
Figgie, M. P;
Hallegua, D. S;
Prete, P. E;
Rosenbaum, J. T;
Stebulis, J. A;
Bosch, F van den;
Yu, D. T;
Miller, A. S;
Reveille, J. D;
Caplan, L.
OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conduct...
Espondilite Anquilosante/tratamento farmacológico,
Espondilartrite/tratamento farmacológico,
Anti-Inflamatórios não Esteroides/uso terapêutico,
Antirreumáticos/uso terapêutico,
Glucocorticoides/uso terapêutico,
Fator de Necrose Tumoral alfa/uso terapêutico,
Infliximab/uso terapêutico,
Adalimumab/uso terapêutico,
Etanercepte/uso terapêutico,
Modalidades de Fisioterapia,
Espondilite Anquilosante/terapia
"AIM:
Non-radiographic axial spondyloarthritis (nr-axSpA) is axial inflammatory arthritis where plain radiographic damage is not evident. An unknown proportion of these patients will progress to ankylosing spondylitis (AS). The increasing recognition of nr-axSpA has been greatly assisted by the widesprea...
